{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:17:36Z","timestamp":1760552256731,"version":"3.41.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014674","name":"Conseil r\u00e9gional du Grand Est","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014674","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9gion Grand Est"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>As new SARS-CoV-2 variants emerge and as treatment of COVID-19 ARDS remains exclusively supportive, there is an unmet need to better characterize its different phenotypes to tailor personalized treatments. Clinical, biological, spirometric and CT data hardly allow deciphering of Heavy (H), Intermediate (I) and Light (L) phenotypes of COVID-19 ARDS and the implementation of tailored specific strategies (prone positioning, PEEP settings, recruitment maneuvers). We hypothesized that the ratio of two pivotal COVID-19 biomarkers (interleukin 6 [IL-6] and Krebs von den Lungen 6 [KL-6], related to inflammation and pneumocyte repair, respectively) would provide a biologic insight into the disease timeline allowing 1) to differentiate H, I and L phenotypes, 2) to predict outcome and 3) to reflect some of CT findings.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>This was a retrospective analysis of prospectively acquired data (COVID HUS cohort). Inclusion concerned any patient with severe COVID-19 pneumonia admitted to two intensive care units between March 1<jats:sup>st<\/jats:sup> and May 1<jats:sup>st<\/jats:sup>, 2020, in a high-density cluster of the first epidemic wave (Strasbourg University Hospital, France). Demographic, clinical, biological (standard, IL-6 [new generation ELISA], KL-6 [CLEIA technique]), spirometric (driving pressure, respiratory system compliance) and CT data were collected longitudinally. CT analysis included semi-automatic and automatic lung measurements and allowed segmentation of lung volumes into 4 (poorly aerated, non-aerated, overinflated and normally aerated) and 3 (ground-glass, restricted normally aerated, and overinflated) zones, respectively. The primary outcome was to challenge the IL-6\/KL-6 ratio capacity to decipher the three COVID-19 ARDS phenotypes (H, I and L) defined on clinical, spirometric and radiologic grounds. Secondary outcomes were the analysis of the prognostic value of the IL-6\/KL-6 ratio and its correlates with CT-acquired data. Multivariate analysis was based on principal component analysis.<\/jats:p>\n<jats:p>One hundred and forty-eight ventilated COVID-19 ICU patients from the COVID HUS cohort were assessed for eligibility and 77 were included in the full analysis. Most were male, all were under invasive mechanical ventilation and vasopressor therapy and displayed high severity scores (SAPSII: 48 [42\u201356]; SOFA: 8 [7\u201310]). The L, I and H COVID ARDS phenotypes were identified in 11, 15 and 48 patients, respectively. In three patients, the phenotype could not be defined precisely. Thirty patients (39%) died in the ICU and the number of ventilator-free days was 2 [0\u20132] days. The IL-6\/KL-6 ratio was not significantly different between the L, I and H phenotypes and evolved according to similar patterns over time. Surviving and deceased patients displayed an inverse kinetic of KL-6. IL-6 and the IL-6\/KL-6 ratio were linearly associated with ground-glass volume on semi-automatic and automatic CT lung measurements.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In our population of severe ventilated COVID ARDS patients, the IL-6\/KL-6 ratio was not clue to differentiate the H, I and L phenotypes and tailor a personalized ventilatory approach. There was an interesting correlation between IL-6\/KL-6 ratio and ground-glass volume as determined by automated lung CT analysis. Such correlation deserves more in-depth pathophysiological study, at best gathered from a prospective cohort with a larger sample size and histological analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>COVID HUS Trial registration number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04405726\" xlink:type=\"simple\">NCT04405726<\/jats:ext-link><\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0321533","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T20:46:30Z","timestamp":1747860390000},"page":"e0321533","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does the IL-6\/KL-6 ratio distinguish different phenotypes in COVID-19 Acute Respiratory Distress Syndrome? An observational study stemmed from prospectively derived clinical, biological, and computed tomographic data"],"prefix":"10.1371","volume":"20","author":[{"given":"Nicolas","family":"Partouche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Maumy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-477X","authenticated-orcid":true,"given":"Thien-Nga","family":"Chamaraux-Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-8281","authenticated-orcid":true,"given":"Frederic","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Solis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Fafi-Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Noll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6073-4354","authenticated-orcid":true,"given":"Julien","family":"Pottecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"pone.0321533.ref001","author":"WHO"},{"issue":"20","key":"pone.0321533.ref002","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"S Richardson","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"pone.0321533.ref003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","volume":"47","author":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0321533.ref004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ebnurs-2020-103370","article-title":"Critical care survival rates in COVID-19 patients improved as the first wave of the pandemic developed","volume":"25","author":"ML Bateson","year":"2022","journal-title":"Evid Based Nurs"},{"issue":"6","key":"pone.0321533.ref005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?","volume":"46","author":"L Gattinoni","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0321533.ref006","doi-asserted-by":"crossref","first-page":"2001768","DOI":"10.1183\/13993003.01768-2020","article-title":"The perils of premature phenotyping in COVID-19: a call for caution","volume":"56","author":"LDJ Bos","year":"2020","journal-title":"Eur Respir J"},{"issue":"2","key":"pone.0321533.ref007","doi-asserted-by":"crossref","first-page":"2002429","DOI":"10.1183\/13993003.02429-2020","article-title":"Building the house of CARDS by phenotyping on the fly","volume":"56","author":"R Rajendram","year":"2020","journal-title":"Eur Respir J"},{"issue":"11","key":"pone.0321533.ref008","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00134-024-07593-3","article-title":"Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients","volume":"50","author":"N Bruse","year":"2024","journal-title":"Intensive Care Med"},{"issue":"2","key":"pone.0321533.ref009","doi-asserted-by":"crossref","first-page":"2002195","DOI":"10.1183\/13993003.02195-2020","article-title":"COVID-19 phenotypes: leading or misleading?","volume":"56","author":"L Gattinoni","year":"2020","journal-title":"Eur Respir J"},{"issue":"9","key":"pone.0321533.ref010","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1164\/rccm.202005-2046OC","article-title":"Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic","volume":"202","author":"R Panwar","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0321533.ref011","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00134-020-06057-8","article-title":"Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection","volume":"46","author":"Lille COVID-19 ICU and Anatomopathology Group","year":"2020","journal-title":"Intensive Care Med"},{"issue":"2","key":"pone.0321533.ref012","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"M Ackermann","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0321533.ref013","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.202003-0527LE","article-title":"Lung Recruitability in COVID-19-associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study","volume":"201","author":"C Pan","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0321533.ref014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13613-020-00675-7","article-title":"Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome","volume":"10","author":"FM Beloncle","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"12","key":"pone.0321533.ref015","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.4187\/respcare.06422","article-title":"Accuracy of the Ventilator Automated Displayed Respiratory Mechanics in Passive and Active Breathing Conditions: A Bench Study","volume":"64","author":"EG Daoud","year":"2019","journal-title":"Respir Care"},{"issue":"162","key":"pone.0321533.ref016","doi-asserted-by":"crossref","first-page":"210138","DOI":"10.1183\/16000617.0138-2021","article-title":"COVID-19 pneumonia: pathophysiology and management","volume":"30","author":"L Gattinoni","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"9","key":"pone.0321533.ref017","article-title":"In Silico Modeling of Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Pathophysiologic Insights and Potential Management Implications","volume":"2","author":"A Das","year":"2020","journal-title":"Crit Care Explor"},{"issue":"10224","key":"pone.0321533.ref018","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","volume":"395","author":"A Zumla","year":"2020","journal-title":"Lancet"},{"key":"pone.0321533.ref019","doi-asserted-by":"crossref","first-page":"108652","DOI":"10.1016\/j.clim.2020.108652","article-title":"Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned","volume":"223","author":"VA Ryabkova","year":"2021","journal-title":"Clin Immunol"},{"issue":"1","key":"pone.0321533.ref020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"J Wang","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"12","key":"pone.0321533.ref021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/jir.2020.0210","article-title":"Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review","volume":"40","author":"BM Liu","year":"2020","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"pone.0321533.ref022","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10787-022-00992-2","article-title":"COVID-19 and the role of cytokines in this disease","volume":"30","author":"A Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"6","key":"pone.0321533.ref023","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19","volume":"13","author":"Y Zhou","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"10229","key":"pone.0321533.ref024","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"pone.0321533.ref025","article-title":"The role of interleukin-6 in monitoring severe case of coronavirus disease 2019","volume":"12","author":"T Liu","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"3","key":"pone.0321533.ref026","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"N Kohno","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"pone.0321533.ref027","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease","volume":"21","author":"JS Lee","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"pone.0321533.ref028","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/jmv.26793","article-title":"Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis","volume":"93","author":"K Deng","year":"2021","journal-title":"J Med Virol"},{"key":"pone.0321533.ref029","doi-asserted-by":"crossref","first-page":"747570","DOI":"10.3389\/fmed.2022.747570","article-title":"Differentiating Phenotypes of Coronavirus Disease-2019 Pneumonia by Electric Impedance Tomography","volume":"9","author":"A Lovas","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"pone.0321533.ref030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41231-022-00122-8","article-title":"COVID-19: positive experience with differentiated tactics of mechanical ventilation of the lungs for different phenotypes (L-phenotype)","volume":"7","author":"V Piacherski","year":"2022","journal-title":"Transl Med Commun"},{"issue":"1","key":"pone.0321533.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SHK.0000000000001825","article-title":"Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis","volume":"57","author":"S Gando","year":"2022","journal-title":"Shock"},{"issue":"3","key":"pone.0321533.ref032","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1152\/japplphysiol.00742.2020","article-title":"Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications","volume":"130","author":"NM Habashi","year":"2021","journal-title":"J Appl Physiol (1985)"},{"issue":"12","key":"pone.0321533.ref033","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S2213-2600(21)00365-9","article-title":"Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts","volume":"9","author":"LDJ Bos","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10358","key":"pone.0321533.ref034","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes","volume":"400","author":"LDJ Bos","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"pone.0321533.ref035","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S2213-2600(22)00294-6","article-title":"Opportunities for improved clinical trial designs in acute respiratory distress syndrome","volume":"10","author":"KD Wick","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"11","key":"pone.0321533.ref036","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1111\/ajt.16251","article-title":"In-depth virological assessment of kidney transplant recipients with COVID-19","volume":"20","author":"I Benotmane","year":"2020","journal-title":"Am J Transplant"},{"issue":"7624","key":"pone.0321533.ref037","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"E von Elm","year":"2007","journal-title":"BMJ"},{"issue":"24","key":"pone.0321533.ref038","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study","volume":"270","author":"JR Le Gall","year":"1993","journal-title":"JAMA"},{"issue":"7","key":"pone.0321533.ref039","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"JL Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0321533.ref040","doi-asserted-by":"crossref","first-page":"100780","DOI":"10.1016\/j.accpm.2020.10.014","article-title":"A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome","volume":"40","author":"E Noll","year":"2021","journal-title":"Anaesth Crit Care Pain Med"},{"key":"pone.0321533.ref041","volume-title":"Applied Mixed Models in Medicine","author":"H Brown","year":"2015"},{"issue":"4","key":"pone.0321533.ref042","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1198\/108571105X80194","article-title":"Regression spline mixed modelsForestry example","volume":"10","author":"ML Mackenzie","year":"2005","journal-title":"J Agric Biol Environ Stat"},{"key":"pone.0321533.ref043","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3035-4","volume-title":"Practical data analysis for designed experiments","author":"BS Yandell","year":"1997"},{"key":"pone.0321533.ref044","doi-asserted-by":"crossref","DOI":"10.1201\/b21874","volume-title":"Exploratory multivariate analysis by example using R","author":"F Husson","year":"2017"},{"issue":"1","key":"pone.0321533.ref045","article-title":"FactoMineR: AnRPackage for Multivariate Analysis","volume":"25","author":"S L\u00ea","year":"2008","journal-title":"J Stat Soft"},{"issue":"1","key":"pone.0321533.ref046","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v070.i01","article-title":"missMDA: A Package for Handling Missing Values in Multivariate Data Analysis","volume":"70","author":"J Josse","year":"2016","journal-title":"J Stat Soft"},{"issue":"11","key":"pone.0321533.ref047","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1080\/00949655.2015.1104683","article-title":"Multiple imputation for continuous variables using a Bayesian principal component analysis","volume":"86","author":"V Audigier","year":"2015","journal-title":"Journal of Statistical Computation and Simulation"},{"issue":"3","key":"pone.0321533.ref048","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1214\/aoms\/1177730388","article-title":"Low Moments for Small Samples: A Comparative Study of Order Statistics","volume":"18","author":"C Hastings","year":"1947","journal-title":"Ann Math Statist"},{"issue":"1","key":"pone.0321533.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/aoms\/1177704711","article-title":"The Future of Data Analysis","volume":"33","author":"JW Tukey","year":"1962","journal-title":"Ann Math Statist"},{"key":"pone.0321533.ref050","volume-title":"Desctools: tools for descriptive statistics","author":"A Signorell","year":"2021"},{"issue":"15","key":"pone.0321533.ref051","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.3107","article-title":"Scaling regression inputs by dividing by two standard deviations","volume":"27","author":"A Gelman","year":"2008","journal-title":"Stat Med"},{"issue":"2","key":"pone.0321533.ref052","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA Statement on p-Values: Context, Process, and Purpose","volume":"70","author":"RL Wasserstein","year":"2016","journal-title":"The American Statistician"},{"key":"pone.0321533.ref053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","article-title":"Moving to a World Beyond \u201c p \u2009<\u20090.05\u201d","volume":"73","author":"RL Wasserstein","year":"2019","journal-title":"The American Statistician"},{"key":"pone.0321533.ref054","volume-title":"sjPlot: Data visualization for statistics in social science","author":"D L\u00fcdecke"},{"key":"pone.0321533.ref055","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2021"},{"issue":"11","key":"pone.0321533.ref056","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"D Wang","year":"2020","journal-title":"JAMA"},{"issue":"10223","key":"pone.0321533.ref057","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"C Huang","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"pone.0321533.ref058","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13613-021-00933-2","article-title":"Impact of ICU transfers on the mortality rate of patients with COVID-19: insights from comprehensive national database in France","volume":"11","author":"M-A Sanchez","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"12","key":"pone.0321533.ref059","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00134-020-06281-2","article-title":"Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study","volume":"46","author":"D Chiumello","year":"2020","journal-title":"Intensive Care Med"},{"issue":"12","key":"pone.0321533.ref060","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s00134-020-06192-2","article-title":"Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS","volume":"46","author":"C Ferrando","year":"2020","journal-title":"Intensive Care Med"},{"issue":"8","key":"pone.0321533.ref061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256744","article-title":"D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19","volume":"16","author":"A Poudel","year":"2021","journal-title":"PLoS One"},{"issue":"23","key":"pone.0321533.ref062","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/eurheartj\/ehaa1103","article-title":"C-reactive protein and clinical outcomes in patients with COVID-19","volume":"42","author":"NR Smilowitz","year":"2021","journal-title":"Eur Heart J"},{"key":"pone.0321533.ref063","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"CM Petrilli","year":"2020","journal-title":"BMJ"},{"issue":"15","key":"pone.0321533.ref064","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"C Qin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pone.0321533.ref065","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019","volume":"71","author":"X Chen","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pone.0321533.ref066","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"DE Leisman","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"12","key":"pone.0321533.ref067","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244628","article-title":"Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis","volume":"15","author":"J Gorham","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0321533.ref068","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12931-020-01560-4","article-title":"Could KL-6 levels in COVID-19 help to predict lung disease?","volume":"21","author":"AN Frix","year":"2020","journal-title":"Respir Res"},{"issue":"1","key":"pone.0321533.ref069","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13054-022-04211-w","article-title":"Longitudinal phenotypes in patients with acute respiratory distress syndrome: a multi-database study","volume":"26","author":"H Chen","year":"2022","journal-title":"Crit Care"},{"issue":"7","key":"pone.0321533.ref070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"C Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"pone.0321533.ref071","doi-asserted-by":"crossref","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia","volume":"12","author":"A Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0321533.ref072","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"J Liu","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"pone.0321533.ref073","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1465-9921-12-32","article-title":"KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome","volume":"12","author":"T Kondo","year":"2011","journal-title":"Respir Res"},{"issue":"6","key":"pone.0321533.ref074","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00420.2002","article-title":"Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome","volume":"286","author":"A Ishizaka","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"pone.0321533.ref075","doi-asserted-by":"crossref","DOI":"10.1186\/cc6785","article-title":"Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome","volume":"12","author":"N Nathani","year":"2008","journal-title":"Crit Care"},{"issue":"3","key":"pone.0321533.ref076","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.resinv.2019.02.001","article-title":"Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib","volume":"57","author":"L Bergantini","year":"2019","journal-title":"Respir Investig"},{"issue":"1","key":"pone.0321533.ref077","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1183\/09031936.03.00070303","article-title":"KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome","volume":"23","author":"H Sato","year":"2004","journal-title":"Eur Respir J"},{"issue":"8","key":"pone.0321533.ref078","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"P Spagnolo","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"pone.0321533.ref079","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.resinv.2016.09.003","article-title":"Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis","volume":"55","author":"K Wakamatsu","year":"2017","journal-title":"Respir Investig"},{"issue":"1","key":"pone.0321533.ref080","first-page":"51","article-title":"Analysis of KL-6 and SP-D as disease markers in bird fancier\u2019s lung","volume":"22","author":"R Janssen","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"10","key":"pone.0321533.ref081","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/jmv.26087","article-title":"Serum KL\u20106 concentrations as a novel biomarker of severe COVID\u201019","volume":"92","author":"M d\u2019Alessandro","year":"2020","journal-title":"Journal of Medical Virology"},{"issue":"6","key":"pone.0321533.ref082","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.7150\/ijbs.58825","article-title":"Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients","volume":"17","author":"M Xue","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"7","key":"pone.0321533.ref083","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11547-022-01504-6","article-title":"Association of serum Krebs von den Lungen-6 and chest CT as potential prognostic factors in severe acute respiratory syndrome SARS-CoV-2: a preliminary experience","volume":"127","author":"E Anastasi","year":"2022","journal-title":"Radiol Med"},{"issue":"5","key":"pone.0321533.ref084","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/thoraxjnl-2017-211090","article-title":"Stability of ARDS subphenotypes over time in two randomised controlled trials","volume":"73","author":"K Delucchi","year":"2018","journal-title":"Thorax"},{"issue":"4","key":"pone.0321533.ref085","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.chest.2021.10.012","article-title":"Lung Response to a Higher Positive End-Expiratory Pressure in Mechanically Ventilated Patients With COVID-19","volume":"161","author":"A Protti","year":"2022","journal-title":"Chest"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T20:46:53Z","timestamp":1747860413000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321533"}},"subtitle":[],"editor":[{"given":"Benjamin M.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321533","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}